Iantech
Reno
About Iantech
Iantech has developed advanced micro-interventional technology for cataract surgery. After 50 years of conventional phacoemulsification, Iantech introduces a micro-interventional technique designed to deliver energy-free endocapsular lens fragmentation, giving surgeons control, efficiency and new opportunities to improve their surgical technique. At Iantech, They are working to invent new surgical approaches which can reduce the global footprint of cataract blindness. Using smart, efficient and adaptable micro-interventional technology, Their team is building a new surgical platform to catalyze global outreach efforts as we fight the 25M blindness epidemic in the world
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $8.2M
- Funding stage: M&A
- Last round: Series C (Jul 2017)
- Website: iantechmed.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Information Technology, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/iantech-157980 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.